SOGROYA 6.7 mg/mL (Somapacitan-Beco INJECTION, SOLUTION) 6.7 mg/mL

SOGROYA 6.7 mg/mL is a subcutaneous injection solution containing somapacitan-beco. This medication is used for growth hormone replacement therapy. Learn more about its uses and effects.

Strength

6.7 mg/mL

Pack Size

1 SYRINGE, PLASTIC in 1 CARTON (0169-2030-11) / 1.5 mL in 1 SYRINGE, PLASTIC

Manufacturer / TM Owner

Novo Nordisk

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

SOGROYA 6.7 mg/mL is primarily used for growth hormone replacement therapy. It is designed to address growth hormone deficiencies in adults and children. The medication works by mimicking the effects of natural growth hormone, promoting growth and development. What is SOGROYA used for? It is often prescribed to individuals who have a deficiency in growth hormone production, helping to improve growth rates and overall health.

Side Effects

Common effects of SOGROYA 6.7 mg/mL may include localized reactions at the injection site, such as redness or swelling. Some users might experience headaches, joint pain, or fluid retention. These effects are generally mild and temporary. It is important to monitor for any persistent or severe reactions and consult a healthcare provider if necessary.

Precautions & Warnings

SOGROYA 6.7 mg/mL should be handled with care. Store the medication as directed, typically in a cool place away from direct sunlight. Ensure the syringe is used correctly and disposed of properly. Always follow the instructions provided by your healthcare provider for safe administration. Do not share the medication with others, even if they have similar symptoms.

Avoid Interactions

SOGROYA 6.7 mg/mL may interact with other medications, including those that affect growth hormone levels. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and certain foods may also affect the effectiveness of the medication. Always consult your healthcare provider before starting any new medication while using SOGROYA.

Frequently Asked Questions

SOGROYA 6.7 mg/mL is used for growth hormone replacement therapy in adults and children with growth hormone deficiencies.

SOGROYA 6.7 mg/mL is administered via subcutaneous injection. Follow the instructions provided by your healthcare provider for proper administration.

Common side effects may include localized reactions at the injection site, headaches, joint pain, and fluid retention.

SOGROYA 6.7 mg/mL may interact with other medications. Consult your healthcare provider before combining it with other drugs.

Store SOGROYA 6.7 mg/mL in a cool place away from direct sunlight. Follow the storage instructions provided with the medication.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.